Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaney L Barratt

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Clinical Immunology (Orlando, Fla.)|April 4, 2024
Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with "idiopathic" interstitial lung diseaseSarah L Tansley, Fionnuala McMorrow, Caroline V Cotton, et al.
Eclinicalmedicine|December 9, 2022
Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosisTheresia A Mikolasch, Peter M George, Jagdeep Sahota, et al.
Rheumatology (Oxford, England)|September 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive diseaseDavid Roofeh, Kevin K Brown, Ella A Kazerooni, et al.
BMJ Open Respiratory Research|September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
ERJ Open Research|January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UKGiles Dixon, Samuel Hague, Sarah Mulholland, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2022
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 StudyIain Stewart, Joseph Jacob, Peter M George, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Clinical Immunology (Orlando, Fla.)|April 4, 2024
Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with "idiopathic" interstitial lung diseaseSarah L Tansley, Fionnuala McMorrow, Caroline V Cotton, et al.
Eclinicalmedicine|December 9, 2022
Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosisTheresia A Mikolasch, Peter M George, Jagdeep Sahota, et al.
Rheumatology (Oxford, England)|September 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive diseaseDavid Roofeh, Kevin K Brown, Ella A Kazerooni, et al.
BMJ Open Respiratory Research|September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
ERJ Open Research|January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UKGiles Dixon, Samuel Hague, Sarah Mulholland, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2022
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 StudyIain Stewart, Joseph Jacob, Peter M George, et al.
Pageof 5